MHTX
$0.02
Manhattan Scients
$.00
38.79%
MHTX
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Nov 18
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when MHTX reports earnings?
Beat
Meet
Miss

Where is MHTX's stock price going from here?
Up
Flat
Down
Stock chart of MHTX
Analysts
Summary of analysts' recommendations for MHTX
Score
Grade
Pivots
Resistance
$0.02
$0.02
$0.02

$0.02

Support
$0.01
$0.01
$0.01
Tweet
Growth
Description
Manhattan Scientifics Inc. is a technology solutions provider that focuses on the nanomedicine space. The Company acts as a technology incubator that acquires, develops and commercializes life-enhancing technologies in various fields, with emphasis in the areas of alternative energy, and consumer and commercial electronics. Manhattan has three wholly owned subsidiaries of which Metallicum is the only operating subsidiary; and Tamarack and Teneo are dormant. Metallicum is a nanotechnology start-up company that focuses on the development and manufacture of nanostructured metals for medical implants and other applications. Metallicum's initial products include nanostructured bulk metals and alloys in the form of rod, bar, wire and foil. Manhattan Scientifics Inc. conducts its operations primarily in the United States and has its offices in New Mexico, New York and Montreal.
Peers
MedtronicVarian Medical SystemsCONMED